Smith Nancy Freda
Reporting owner on Forms 3, 4 and 5, CIK 2019811.
Smith Nancy Freda reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Tempest Therapeutics, Inc. CIK 1544227 | director | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. Stock Option (right to buy), derivative | 2026-09-22 | A granted | +25,000 | $0 | 25,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001213900-26-106400 | Tempest Therapeutics, Inc. | 2026-10-02 | ||
| Form 3 0001213900-26-106399 | Tempest Therapeutics, Inc. | 2026-10-02 |